文献速递瓣膜病与结构性心脏病血脂与心血管预防

病毒性或特发性心包炎住院后发病与死亡的风险因素

Risk Factors for Morbidity and Mortality Following Hospitalization for Pericarditis.
PubMed 文献 · J Am Coll Cardiol · 2020-01-01

基于丹麦全国注册数据,1996至2016年首次诊断心包炎且无严重基础心脏病的7988例患者与79880名匹配对照相比,5年绝对生存率分别为92.9%和95.8%,校正风险比1.31(95%CI 1.13-1.52),女性死亡率差异更明显,且心血管与非心血管再入院率均更高。

要点

  • 病毒性或特发性心包炎患者5年死亡风险高于匹配对照,校正HR 1.31(95%CI 1.13-1.52)。
  • 死亡风险差异在诊断后第一年最大,且主要由女性人群驱动。
  • 心包炎组心血管与非心血管疾病再入院率均高于对照,需关注潜在基础疾病。

核心结论

  • 病毒性或特发性心包炎患者5年死亡风险高于匹配对照人群,女性尤为明显。
  • 该类患者心血管与非心血管疾病再入院率均更高,提示需关注潜在基础疾病。

研究设计与样本

  • 基于丹麦全国注册的回顾性匹配队列研究,纳入1996至2016年首次出院诊断心包炎且排除严重基础心脏病的患者。
  • 共识别7988例心包炎患者,按性别和出生年份1:10匹配79880名一般人群对照。
  • 采用Kaplan-Meier法评估5年生存率,Cox比例风险模型校正基线合并症。

主要发现

  • 心包炎组5年绝对生存概率为92.9%,对照组为95.8%。
  • 校正后死亡风险比1.31(95%CI 1.13-1.52)。
  • 死亡率差异在诊断后第一年最大,且主要由女性人群驱动。
  • 心包炎组新发需住院诊断的心血管和非心血管疾病每1000人年发生率均高于对照组。

临床怎么用

  • 对病毒性或特发性心包炎住院患者,应评估并管理心血管及非心血管基础疾病。
  • 尤其对女性患者,需关注随访期间死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Viral or idiopathic pericarditis is a frequent condition, often considered benign, although prior studies have suggested that pericarditis is associated with both cardiovascular and noncardiovascular disease, for example, malignancy. OBJECTIVES: This study sought to assess mortality risk and morbidity patterns in patients with incident viral or idiopathic pericarditis. METHODS: In nationwide Danish registries, we identified patients discharged with a first-time diagnosis of pericarditis from 1996 to 2016. Patients with a severe underlying heart condition were excluded. The patients were matched 1:10 with individuals from the general population by sex and year of birth. We assessed 5-year mortality using Kaplan-Meier and Cox proportional hazards models adjusted for baseline comorbidities and identified subsequent hospital admissions. RESULTS: We identified 7,988 patients with pericarditis and 79,880 matched control individuals. The absolute 5-year survival probability was 92.9% and 95.8% in the pericarditis and control groups, respectively (adjusted hazard ratio: 1.31; 95% confidence interval: 1.13 to 1.52). The greatest difference in mortality was seen the first year, and it was primarily driven by the female part of the population. The incidence rate per 1,000 person-years of new-onset, admission-required diagnosis was higher in the pericarditis group both for cardiovascular and noncardiovascular diseases. CONCLUSIONS: We observed a higher mortality risk over 5 years in the pericarditis group, especially among the female patients, compared to matched control individuals. Furthermore, we observed a higher frequency of both cardiovascular and noncardiovascular hospital admissions, highlighting the need for focus on underlying morbidity in patients presenting with apparent viral or idiopathic pericarditis.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Sigvardt FL, Hansen ML, Kristensen SL, et al. Risk Factors for Morbidity and Mortality Following Hospitalization for Pericarditis. J Am Coll Cardiol. 2020. PMID: 33243382. doi:10.1016/j.jacc.2020.09.607

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。